Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 52 results:
Author Title Type [ Year] Filters: Keyword is Antibodies, Monoclonal [Clear All Filters]
(2021).
Inconsistent high sensitivity troponin T and I measurements in a patient with rheumatoid arthritis..
Hellenic J Cardiol. 60(1), 59-60.
(2019). New therapeutic targets for osteoporosis..
Maturitas. 120, 1-6.
(2019).
(2018).
(2018).
The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins..
Curr Pharm Des. 23(10), 1477-1483.
(2017). Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors..
Mycoses. 60(8), 493-507.
(2017). Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors..
Mycoses. 60(4), 222-229.
(2017). Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever..
J Rheumatol. 44(1), 102-109.
(2017). Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström's macroglobulinemia..
Leuk Lymphoma. 58(6), 1506-1508.
(2017). The Role of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in the Management of Dyslipidemia..
Curr Pharm Des. 23(10), 1495-1499.
(2017). Scalp psoriasis and biologic agents: a retrospective, comparative study from a tertiary psoriasis referral centre..
J Eur Acad Dermatol Venereol. 30(12), 2091-2096.
(2016). Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia..
Ann Intern Med. 163(3), 241.
(2015). Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-TNF-α monoclonal antibody: an observational multicenter study..
J Eur Acad Dermatol Venereol. 29(12), 2363-8.
(2015). Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study..
J Dermatolog Treat. 25(1), 73-4.
(2014). Secukinumab for ankylosing spondylitis..
Lancet. 383(9919), 780.
(2014). eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese..
Ann Rheum Dis. 72(5), e7.
(2013). HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients..
Br J Cancer. 108(3), 668-75.
(2013). Invasive candidiasis: update on current pharmacotherapy options and future perspectives..
Expert Opin Pharmacother. 14(11), 1515-28.
(2013). Budget impact analysis of ustekinumab in the management of moderate to severe psoriasis in Greece..
BMC Dermatol. 12, 10.
(2012). Pure red cell aplasia and lymphoproliferative disorders: an infrequent association..
ScientificWorldJournal. 2012, 475313.
(2012). Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesis..
Med Hypotheses. 77(1), 109-11.
(2011). Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization..
Acta Ophthalmol. 89(3), 218-21.
(2011). Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer..
Breast Cancer Res Treat. 128(2), 447-56.
(2011).
(2011).